Pancrelipase
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171977This classification denotes an adverse event associated with metabolic and laboratory abnormalities with the molecular formula C5850H8902N1606O1739S49, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FQ3DRG0N5K, more generally known as pancrelipase. European Medicines Agency schedules pancrelipase in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14362MIG. The term PANCRELIPASE is an International Non-Proprietary Name or INN. As of Q4 2014, PANCRELIPASE remains the US FDA Preferred Term for this commodity.
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.